Chemical Pathology Flashcards
Primary hyperparathyroidism caused by hyperplasia is associated with which gene
MEN1 (multiple endocrine neoplasia type 1)
Is primary hyperparathyroidism more common in men or women?
Women
The commonest cause of hypercalcaemia is
Primary hyperparathyroidism
Blood results in primary hyperparathyroidism
PTH
Calcium
Phosphate
PTH inappropriately normal or high
Calcium high
Phosphate low
Congenital absence of parathyroids is known as
DiGeorge syndrome
Causes of low calcium due to low PTH
Surgical including post thyroidectomy
Auto-immune hypoparathyroidism
DiGeorge syndrome (congenital absence of parathyroids)
Mg Deficiency
Formula for osmolality
Osmolality= cations+anions+urea+glucose
So
Osmolality= Na+K+Cl+HCO3+urea+glucose
since anions=cations this can be reduced to
Osmolality 2(Na+K) + Urea+ Glucose
Formula for anion gap
Na + K - Cl - Bicarb
Normal anion gap=
Approximately 18mM
…+… injected is known as speedball
Cocaine
Heroin
Acute dangers of cocaine:
Cardiac dysrhythmias, MI, Acute heart failure
Fatal dose of methadone in a healthy adult:
60ml
Fatal dose of methadone in a child
5ml
Benzodiazepine antidote
flumazenil
Problems with interpreting post-mortem blood toxicology
PM redistribution of drugs
Degradation of drugs post mortem e.g. cocaine
Individual variation in response (tolerance)
Site dependence
Why use hair for post mortem toxicology?
Blood/serum, drugs typically can be detected for no more than 12 hours
Urine, drugs typically detected for 2-3 days
Hair is the only specimen can give information about long term drug use
Drugs are incorporated into hair from the blood stream during the growth phase
Hair growth approx 1cm/month – “tape-recording of drug use”
Problems with hair analysis for post mortem toxicology
Environmental Contamination Absorbed from sweat or sebum coating hair Passive inhalation Cosmetic treatment Shampoo washing Perming, dyeing, bleaching Hair colour
Most common causes of death after heroin use
Respiratory depression
Aspiration pneumonitis
Applications of hair analysis (toxicology)
Applications of hair analysis
• Child custody cases
• Investigating spiked drinks defences
• Drug naïve deaths
• Monitoring drug use prior to return of driving license – Germany, Italy
• Investigation of drug use in exhumed/putrefied bodies
• Employment, pre-employment screening - USA
Causes of metabolic acidosis
- Increased H+ production e.g. diabetic ketoacidosis
- Decreased H+ excretion e.g. Renal tubular acidosis
- Bicarbonate loss e.g. intestinal fistula
Types of renal tubular acidosis. Brief pathogenesis
Type 1 is distal: due to failure of alpha cells in collecting ducts to secrete H+ into urine. Due to autoimmune e.g. RA, drugs e.g. lithium, genetics and hypercacliuric conditions e.g. hyperPTH
Type 2 is proximal: caused by decrease in bicarbonate reabsorption. Caused by genetics, amyloidosis, multiple myeloma, HAART (HIV meds), basically anything that causes deposits in kidneys.
Type 3: combo of 1 and 2. Not used.
Type 4: Caused by hypoaldosteronism or resistance to aldosterone e.g. CAH, primary hypoaldosteronism, NSAIDs, ACEi, Aldosterone blockers, sarcoidosis.
Causes of metabolic alkalosis
Ingestion of bicarb
Reduced H+ excretion e.g. pyloric stenosis
Hypokalaemia
Management of hypovolaemia hyponatraemia due to diuretics
Stop diuretic
0.9% NaCl
Causes of euvolaemic hyponatraemia
SIADH
Hypothyroidism
Adrenal insufficiency
Causes of hypovolaemic hyponatraemia
Diuretics
Diarrhoea
Vomiting
Salt losing nephropathy
Causes of hypervolaemic hyponatraemia
Cirrhosis
Cardiac failure
Nephrotic syndrome
Features of SIADH
No hypovolaemia
High urine osmolality (over 100)
Low plasma osmolality
Causes of SIADH
CNS pathology
Lung pathology
Drugs (SSRI, TCA, opiates, PPIs, carbamazepine)
Tumours (most likely small cell lung cancers)
Investigations in suspected diabetes insipidus
Serum glucose (exclude diabetes mellitus)
Serum potassium (exclude hypokalaemia)
Serum calcium (exclude hypercalcaemia)
Plasma & urine osmolality (high plasma osmolality, and low urine osmolality)
Water deprivation test
Key features of ECG in hyperkalaemia
Peaked/tented T waves
Absent p waves
Broad complexes
Management of hyperkalaemia
10 ml 10% calcium gluconate
50 ml 50% dextrose + 10 units of insulin
Nebulised salbutamol
Treat the underlying cause
Features of primary hyperaldosteronism
Hypertension (resistant to treatment)
Low potassium
High sodium
High aldosterone, low renin (negative feedback)
Causes of hyperkalaemia
Renal impairment
Drugs (e.g. spironolactone, ACEi, A2RBs)
Adrenal insufficiency (Addison’s disease)
Rhabdomyloysis
Acidosis (hydrogen moves into cells, potassium leaves cells)
Type 4 renal tubular acidosis (rare)
Drive for potassium secretion in distal nephron
Na reabsorption through ENaC (epithelial sodium channels) leads to tubular lumen negative electrical potential, driving potassium secretion.
Happens in the principal cells of the collecting tubule.
How does aldosterone increase potassium secretion?
Aldosterone increases transcription of genes for:
Epithelial sodium channels in collecting tubule (lumen side)
Basolateral sodium/potassium pumps in collecting tubule
So Na absorption is increased
Na reabsorption through ENaC (epithelial sodium channels) leads to tubular lumen negative electrical potential, driving potassium secretion.
Stimuli for aldosterone secretion
Angiotensin II
Potassium
Causes of hypokalaemia
GI loss: D+V
Renal loss: Loop and thiazide diuretics, Barrter syndrome, Gitelman syndrome, excess aldosterone, excess cortisol
Redistribution into cells
What is Barrter syndrome
A rare inherited defect in the thick ascending limb of the loop of Henle.Causes low potassium levels. Caused by mutations in genes for multiple proteins leading to a similar outcome
What is Gitelman syndrome
Defect in Na/Cl co-transporters in distal tubule. Leads to hypokalaemia
Clinical features of hypokalaemia
Muscle weakness
Cardiac arrhythmia
Polyuria and polydipsia (nephrogenic DI, hypokalaemia makes you resistant to ADH)
Management of hypokalaemia
Serum potassium 3.0-3.5 mmol/L:
Oral potassium chloride (two SandoK tablets tds for 48 hrs)
Recheck serum potassium
Serum potassium 20 mmol per hour are highly irritating to peripheral veins
Treat the underlying cause e.g. give spironolactone for Conn’s
Glucagon is not effective in patients with…
Liver failure
They have no glycogen stores
Treatment for hypoglycaemia (acute) if: Alert and orientated Drowsy/confused but swallow intact Unconconcious/ concerns about swallow Deteriorating / refractory /insulin induced /difficult IV access
Rapid acting oral carbohydrates e.g. Lucozade
Buccal glucose e.g. hypostop
IV access: 50ml 50% glucose (Do not do this in real life!)
Consider IM/SC 1mg glucagon
Which patients (with diabetes) most commonly experience no symptoms with hypoglycaemia
Patients on B-blockers
Patients who have recurrent hypoglycaemia
First response to hypoglycaemia (substance released/suppressed). Followed by…
Suppression of insulin
THEN
Release of glucagon
Release of adrenaline
Release of cortisol
End product of glycogen breakdown in muscle
Glucose-6 phosphate
C-peptide is
The cleavage product of pro-insulin (along with insulin).
Secreted in equimolar amounts to insulin
Half life of c-peptide
Half-life of insulin
4-6 minutes
30 minutes
The 3 ketone bodies
Acetone (pear drop smell in pts with DKA and is volatile), beta hydro and acetoacetate
Inherited metabolic disorders leading to hypoketotic hyooglycaemia in neonates
FAOD : no ketones produced
GSD type 1 ( gluconeogentic disorder)
Medium chain acyl coA dehydrogenase def.
Carnitine disorders
Beckwith Weidemann syndrome is…
An overgrowth disorder usually present at birth. Characterised by certain features including:
neonatal hypoglycaemia (islet cell hyperplasia)
macgroglossia
Macrosomia
Midline abdominal wall defects
Hepatoblastoma
Ear creases or ear pits
Mechanism of action of sulphonylureas
Bind to Sur 1 subunit of potassium channel (on insulin secreting cell) and cause it to close. Membrane depolarisation leads to insulin release
MEN1 is associated with tumours of the…
Pituitary
Parathyroid
Pancreas
How does Non-islet cell tumour cause hypoglycaemia
Tumour secretes “big IGF-2” which binds to IGF-1 receptors and insulin receptors. Produces downstream effects of insulin
Quinine causes hypoglycaemia by…
Stimulating insulin secretion
`Rate limiting step in haem biosynthesis
Creation of 5-Aminolaevulinic Acid (ALA) from succinyl-CoA and glycine.
Enzyme: ALA synthase